Research consortia in Europe often compete with each other for skills, human and technical resources and, eventually, recognition of the scientific impact of their work. In response to the same EU Horizon2020 call, we received funding for our research project proposals to identify and validate novel drug targets for cardiovascular disease treatment. Each consortium followed a unique and independent research strategy. However, as coordinators of these consortia we envisioned we could increase impact, outcomes and efficiency by intensifying our interaction. At an agreed stage during our projects we chose to share our knowledge, vision and ideas. In this paper we present what we learned, in the hope that future consortia will see the benefits of this approach.

中文翻译：

---

分享整个欧洲心血管研究联合会的经验教训。

欧洲的研究联盟经常相互竞争以争夺技能，人力和技术资源，并最终承认他们工作的科学影响。为了响应欧盟Horizo​​n2020的同一号召，我们获得了用于研究项目建议的资金，以鉴定和验证用于心血管疾病治疗的新型药物靶标。每个联盟都遵循独特且独立的研究策略。但是，我们设想，作为这些财团的协调员，我们可以通过加强互动来增加影响，成果和效率。在项目的商定阶段，我们选择分享我们的知识，愿景和想法。在本文中，我们介绍了我们学到的东西，希望未来的联合会能够看到这种方法的好处。